+86-21-58356573
LANGUAGE

Company news

ImmuneOnco Biopharma received 500 thousand yuan project funds supported by Shanghai Economic and Information Committee

2018-4-2 0:00:00Click:160

      On March 30, 2018, ImmuneOnco Biopharma Co., Ltd., an emerging biotech company fully focusing on discovery and development of tumor immunotherapy, received 500 thousand yuan project funds supported by Shanghai Economic and Information Committee. The project won the supportion in 2017 by Shanghai industrial transformation and upgrading of special funds project; the project No.: 17XI-23. 

      Its first patent titled with “Recombinant Bi-functional Fusion Proteins, Preparations and Methods for Treating Disease” (U.S. Patent No. US9527901B2) has been granted in the United States. This patent was originally invented by Macroimmune Inc which was acquired recently by ImmuneOnco. The new patent covers both composition-of-matter and method of treatment claims for the bi-functional protein.